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Background/aim: Bone morphogenetic protein-15 (BMP-15) is one of the maturation indicators of the ovarian follicular pool. The aim
of this study was to investigate the possible difference of follicular fluid (FF) BMP-15 RNA expression among low, normal, and high
responder women attending controlled ovarian hyperstimulation-intracytoplasmic sperm injection (COH-ICSI) cycles.
Materials and methods: This cross-sectional study was conducted with 75 FFs of COH-ICSI cycles performed at the IVF Unit of
University Hospital. Twenty FF from low response (group 1), 27 FF from normal response (group 2), and 28 FF from high response
(group 3) were recruited for the study between September 2014 and February 2015. Cycle parameters were collected from patient files.
FF BMP-15 RNA expression was evaluated with real-time polymerase chain reaction analysis. Statistical analysis was done with SPSS
16.0 version (SPSS Chicago, IL, USA).
Results: The mean age, infertility duration, and body mass index (BMI) of patients were 31.1 ± 4.4 years, 7.4 ± 4.5 years, and 25.6 ± 4.1
kg/m2, respectively. There was no significant difference among groups for age, infertility duration, and BMI. There was no significant
difference among groups for fertilization rate, implantation rate, pregnancy rate, and live birth rate. Among the 3 groups, FF BMP-15
RNA overexpression and lower expression rates were not significantly different. In all groups, overexpression showed dominance. The
pregnancy rate was 45% among women with lower expression and the pregnancy rate among women with overexpression was 26% (P =
0.02). BMP-15 overexpression showed impact on becoming pregnant (OR = 3.7, 95% CI = 1.245–11.299, P = 0.019).
Conclusion: In this study, there was no significant difference in FF BMP-15 RNA expression levels among low, normal, and high
responder women. However, overexpression of FF BMP-15 RNA showed a negative impact on pregnancy rates of women who attended
COH-ICSI cycles.
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1. Introduction
Assisted reproductive technologies (ART) aim to improve
the fertility capacity of infertile couples. Most of the ART
interventions such as controlled ovarian hyperstimulation
(COH), oocyte collection (OPU), and embryo transfer (ET)
are performed on women. Each of these steps has an impact
on cycle outcome. The primary outcome of the COH cycle
is the collected mature oocyte number [1]. A mature oocyte
is the hallmark of COH and is dependent on the interaction
between stimulation protocol and ovarian response.
The ovarian response is determined objectively with
preovulatory follicular development and blood estradiol
levels [1]. Recently, researchers investigated the follicular
fluid (FF) cytokine and growth factor levels for identifying
the possible factors that have an effect on oocyte maturation
[2]. The bone morphogenetic protein-15 (BMP-15) is one of
the regulator proteins of ovarian folliculogenesis [3,4]. The

BMP-15 protein secreted by the oocytes into the ovarian
follicles supports the follicular environment for selection
and growth [5]. While some researchers did not observe
a difference in the parameters of mature oocyte and antral
follicle counts among single nucleotide polymorphism
carriers of BMP-15 gene [6], other researchers reported a
relationship between ovarian hyperstimulation syndrome
and BMP-15 single nucleotide polymorphism [7]. FF BMP15 levels are another investigation topic among researchers
for predicting cycle outcomes [8]. In our study, we intended
to investigate the possible difference in FF BMP-15 RNA
expression levels among women with low, normal, and high
responses undergoing the COH+ET cycle.
2. Materials and methods
This cross-sectional study was conducted with 75 infertile
couples that attended a COH-intracytoplasmic sperm
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injection (ICSI)-ET cycle at the In Vitro Fertilization Unit
of our University Hospital between June 2014 and February
2015. Twenty women with low response (group 1), 27
women with normal response (group 2), and 28 women
with high response (group 3) were recruited for the study.
Age, body mass index, and COH protocol were matched
among the population. The male factor was not included
in this study to prevent bias that can arise from embryonic
development. All participants were informed about the
study and informed signed consent was collected. Local
ethics committee approval was obtained.
2.1. COH-ICSI-ET procedure
All patients attended the GnRH antagonist cycle after a
basal infertility evaluation. COH was started on day (D)
2–3 of the menstrual cycle according to age, D3 follicle
stimulating hormone (FSH) level, and antral follicle count
(AFC) with recombinant FSH (Gonal-F®, Merck İlaç Ecza
ve Kimya A.Ş., İstanbul, Turkey). When the leading follicle
reached 12mm in diameter or blood estradiol level reached
300 pg/mL, 0.25 mg cetrorelix (Cetrotide®, Merck İlaç
Ecza AŞ, Türkiye) was started and continued until final
maturation. When at least three follicles reached 17mm
in diameter, recombinant human chorionic gonadotropin
(hCG) (Ovitrelle®, Merck İlaç Ecza ve Kimya A.Ş.) was
administered for final maturation. Oocyte pick-up (OPU)
was performed at 34–36 h after hCG injection. Following
oocyte retrieval, their cumulus cells were removed by
exposure to 20 IU/mL hyaluronidase (ART-4007A,
SAGE BioPharma, Pasadena, CA, USA) in HEPES-based
medium for 30 s, followed by mechanical pipetting in
HEPES-buffered HTF containing 5 mg/mL human serum
albumin (ART-3001, SAGE BioPharma). The collected FF
samples were centrifuged for 10 min at 2000 × g to remove
the blood and the remaining fluid was stored at –80 °C
until assay.
The patients were divided into 3 groups according to
the collected mature oocyte numbers as follows: group 1
(n = 20): low response group with mature oocyte number
lower than 5; group 2 (n = 27): normal response group
with mature oocyte number between 5–10; group 3 (n
= 28): high response group with mature oocyte number
higher than 10.
In embryology, mature oocytes were inseminated by
ICSI after cumulus separation. Fertilization was defined
as the observation of 2 pronuclei 24 h after ICSI. ET was
performed on day 3 with a single cleavage embryo or on
day 5 with a single blastocyst. Luteal support was done
with daily application of vaginal 8% progesterone gel and
intramuscular 50 mg progesterone. Pregnancy was checked
with blood beta hCG test 14 days after ET. Blood beta hCG
test was repeated 2 days later for confirming the healthy
increment. Transvaginal ultrasonography was performed
for visualization of the gestational sac 10 days later.
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Ongoing pregnancy was defined as the presence of more
than 24 weeks of gestation with a live fetus. Implantation
rate (ImR) was calculated as the ratio of gestational sac
number/transferred embryo number. The fertilization
rate (FR) was calculated as the ratio of fertilized oocyte
number/mature oocyte number. The pregnancy rate (PR)
was calculated as the ratio of beta hCG test positivity/
transferred embryo number. The live birth rate was defined
as live fetus delivery/transferred embryo number.
2.2. BMP-15 RNA expression analysis
2.2.1. RNA isolation, quantification, and qualification
Total RNA from the FFs of each group was isolated using
37 °C Trizol (Reagent Invitrogen, 15596018, California,
USA) according to the manufacturer’s protocol.
2.2.2. Complementary DNA (cDNA) synthesis
OneScript® Revers Transcriptase cDNA Synthesis
Kit [G234, Applied Biological Materials Inc. (abm),
Richmond, BC, Canada] was applied for cDNA synthesis.
Reverse transcriptase reactions included RNA specimens
with purified total RNA, 1 U/μL MultiScribe reverse
transcriptase, 0.25 mM each of dNTPs, 0.25 U/μL RNase
inhibitor, and 1× RT buffer. The specimens were placed
into a thermal cycler and incubated at 25 °C for 10 mins,
at 42 °C for 50 mins, and at 85 °C for 5 min, respectively,
and were conserved at 4 °C. Table 1 presents the primers
of the study [9].
2.2.3. cDNA amplification with real-time polymerase
chain reaction (RT-PCR)
The cDNA fragments produced by reverse transcription
were amplified with RT-PCR by the presence of sequencespecific primers. The RT-PCR was done on repeated
cycling of 3 steps. After the preparation of the RT-PCR
plate, 2 μL of cDNA samples were placed into the wells.
For every sample on ice, 5 μL TaqMan Master Mix, 2.5 μL
nuclease-free water, and 0.5 μL primer hybridization probe
and component amounts were calculated according to the
sample size, placed into Eppendorf tubes, and vortexed.
Eight μL of the prepared mixture were added to the cDNA
samples on the plate and then optic adhesive tape was
used to cover the plate. The samples were centrifuged with
miniplate spinner for 1 min in order to decrease formed

Table 1. Sequence details of polymerase chain reaction (PCR)
primers used to analyze mRNA expression in follicular fluids.
Gene
BMP15
β-actin

Sequence of primers
Forward: CAGTCCTCTATTGCCCTTCT
Reverse: AATGGTGCGGTTCTCTCTA
Forward: GGACTTCGAGCAAGAGATGG
Reverse: AGCACTGTGTTGGCGTACAG
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bubbles and to accomplish precipitation. Real-time PCR
was applied by using a standard Master Mix PCR kit
[Bright Green 2XqPCR Master Mix, Applied Biological
Materials Inc. (abm)] protocol on an Applied Biosystems
7500 Fast Thermal Cycler. The 10 μL PCR contained 1
μLRT product, 1× Taq PCR Master Mix, and 0.5 μM
Taq Master gene-specific assay mix [Applied Biological
Materials Inc. (abm)]. The RT-PCR reactions were carried
out at 95 °C for 10 min, followed by 40 cycles of 95 °C
for 15 s, and 60 °C for 60 s. All reactions were repeated 3
times. Gene expression levels were assessed by using the
Applied Biosystems 7500 real-time PCR system. β-actin
was applied as the control gene.
2.2. Statistical analysis
Statistical analyses were performed with SPSS 16.0 version
(SPSS Chicago, IL, USA). A comparison of continuous
variables between groups was done with Kruskal–Wallis
analysis according to distribution normality of data;
for binary comparisons, the Mann–Whitney U test
was performed. Comparison of categorical variables
was done with the chi-square test or Fisher’s exact test,
where applicable. For investigation of possible relation
and interaction, correlation and regression analyses were
performed, respectively. P value below 0.05 was accepted
as statistically significant. The gene expression profile was
determined by means of nonparametric tests that perform
comparisons 2 by 2. Differences in the gene expression
profile were determined using nonparametric tests with
2 criteria to define the transcripts that had altered the
mRNA abundance of the different sample sets: an absolute
fold change (FC) of 2.0 or more and P < 0.05. Positive
FC values reflect an overexpression and a negative value
denotes underexpression.

difference between groups for age, infertility duration, and
BMI (Table 2). AFC gradually increased from group 1 to
group 3.
The COH parameters of the groups are presented
in Table 3. The collected mature oocyte count (MOC)
and fertilized oocyte count were significantly different
between groups (P < 0.05). While estradiol level on hCG
day and mature and fertilized oocyte numbers gradually
increased from group 1 to group 3, the total gonadotropin
dose gradually decreased from group1 to group 3. The
endometrial thickness on OPU day, progesterone level on
hCG day, and stimulation duration were not significantly
different among groups. FR, PR, and ImR were not
significantly different between groups, and abortion and
live birth rates of groups were not significantly different
either (Table 3).
FF BMP-15 RNA expression rate is presented in Table
4 and on the Figure.
Among the 3 groups, FF BMP-15 RNA overexpression
and lower expression rates were not significantly different
(Table 4). Overexpression showed dominance in all groups.
There was no correlation between FF BMP-15 RNA
expression level and the following parameters: age, BMI,
estradiol and progesterone levels on hCG day, endometrial
thickness on OPU day, FR, PR, and ImR.
The pregnancy rate of women with either lower or
overexpressed BMP-15 RNA is presented in Table 5.
The pregnancy rate was 45% among women with lower
expression and the pregnancy rate among women with
overexpression was 26% (P = 0.02). According to binary
logistic regression, BMP-15 overexpression had impact on
becoming pregnant (OR = 3.7, 95% CI = 1.245–11.299, P
= 0.019).

3. Results
The mean age, infertility duration, and BMI of 75 patients
in the study were 31.1 ± 4.4 years, 7.4 ± 4.5 years, and
25.6 ± 4.1 kg/m2, respectively. There was no significant

4. Discussion
In this study it was observed that FF BMP-15 RNA
expression increased during COH and the expression
level did not show a statistically significant difference

Table 2. Demographic characteristics of patients.
Group 1

Group 2

Group 3

P value

Age (years)

32.7 ± 4.5

30 ± 4.7

30.5 ± 3.6

0.15

Infertility duration (years)

7.9 ± 5.5

6.6 ± 4.1

7.6 ± 3.9

0.63

BMI (kg/m )

25 ± 3.9

25.9 ± 4.2

25.9 ± 4.3

0.75

TSH (mU/L)

1.7 ± 0.5

1.9 ± 0.7

1.9 ± 0.6

0.43

Prolactin (ng/mL)

12.3 ± 4.5

13.3 ± 5

15.6 ± 6.9

0.22

Antral follicle count

5.8 ± 1.7

11.8 ± 2.3

18 ± 3.8

0.00

2

Note: Values are presented as mean±SD. BMI: Body mass index;
TSH: Thyroid-stimulating hormone.
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Table 3. COH and embryology parameters of patients.
Group 1

Group 2

Group 3

P value

Total oocyte count

2.7 ± 1.5

8.5 ± 2.4

12.7 ± 3.8

0.007

Mature oocyte count

1.8 ± 0.9

5.5 ± 2.3

10.7 ± 3.4

0.005

Two pronucleus count

1.4 ± 0.6

3.7 ± 1.5

6 ± 2.7

0.04

Transferred embryo number

1 ± 0.5

1 ± 0.6

1.1 ± 0.6

0.55

Endometrial thickness on day of OPU (mm)

10.5 ± 1.9

11.3 ± 1.2

10.4 ± 1.8

0.36

FSH total dose (IU)

3010 ± 1110

2045 ± 510

1380 ± 300

0.002

Stimulation duration (day)

10.4 ± 1.4

9.7 ± 1.2

11 ± 1

0.06

Progesterone level on hCG day (ng/mL)

0.7 ± 0.3

0.5 ± 0.3

0.7 ± 0.2

0.36

Estradiol level on hCG day (pg/mL)

820 ± 200

1550 ± 670

2350 ± 695

0.045

Fertilization rate (%)

67

69

76

0.36

Pregnancy rate (%)

66

50

54

0.49

Implantation rate (%)

38

29

33

0.86

Abortion rate (%)

10

3.6

11.1

0.54

Preterm birth rate (%)

-

7.1

-

0.87

Live birth rate (%)

25

14.3

22.2

0.48

Note:Values are presented as mean±SD and percentage. COH: Controlled ovarian hyperstimulation;
FSH: Follicle-stimulating hormone; OPU: Oocyte pick-up; hCG: Human chorionic gonadotrophin.
Table 4. BMP-15 RNA expression level among groups.
Group 1

Group 2

Group 3

P value

RNA underexpression (%)

25

25.9

35.7

0.64

RNA overexpression (%)

75

74.1

64.3

0.72

Figure Follicular fluid BMP-15 RNA expression level according to ovarian response to stimulation.

between low, normal, and high responder women. Low,
normal, and high responder women showed similar FR,
PR, and ImR. The live birth rate was also similar among
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rates than women with lower FF BMP-15 RNA expression.
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Table 5. The cross-tabulation between BMP-15 RNA expression and pregnancy rate.
Pregnancy negative

Pregnancy positive

Total (%)

BMP-15 RNA lower expression (%)

55

45

100

BMP-15 RNA over expression (%)

74

26

100

Total (%)

68

32

100

It is suggested that BMP-15 plays a pivotal role in female
fertility [10] and BMP-15 RNA expression is associated
with oocyte maturation [11]. Li et al. investigated the
cumulus cell BMP-15 mRNA expression level of 196 women
suffering from male factor infertility [11]. The stimulation
protocol of 196 subjects was a long GnRH agonist protocol.
Low responders and high responders were not included
in the study. They reported an association between BMP15 mRNA expression level and age, BMI, and oocyte
developmental potential. They observed an association
between cumulus cell BMP-15 mRNA expression level and
pregnancy outcome. BMP-15 RNA expression level was
significantly higher in the group with high-quality embryos
than in the group with nonhigh-quality embryos. They
observed that pregnant women had higher BMP-15 mRNA
levels than women who could not conceive. The results of
this study are different from those of Li et al. There was
no relation between BMP-15 RNA expression level and age
and BMI. And there was a significantly higher level of FF
BMP-15 RNA expression in women who could not achieve
pregnancy. This difference arises from the study population
and design differences. They only investigated normal
responder women with male factor infertility, but in this
study low, normal, and high responder women without
male factor infertility were investigated and pituitary
downregulation was done with GnRH antagonist. This
is another investigation topic for researchers–the GnRH
analog type and its effect on FF BMP-15 RNA expression.
De Resende et al. researched the BMP-15 RNA
expression level difference of cumulus cells derived from
metaphase II oocytes among 18 women suffering from
polycystic ovarian syndrome (PCOS) and 35 controls. Both
groups underwent COH with GnRH agonist suppression.
They observed significantly higher BMP-15 RNA expression
levels in PCOS patients compared to those in controls [12].
In this study, there was no increment on FF BMP-15 RNA
expression level of high responder women compared to
those in both low and normal responders. This difference
may arise from the pituitary downregulation type. De
Resende et al. did not observe a correlation between
cumulus cell BMP-15 RNA expression level and FF steroid
hormone levels [12]. Similarly, in this study, there was no
correlation between FF BMP-15 RNA expression level and
hCG day serum estradiol and progesterone levels. Liu et al.
investigated 5 novel missense mutations of BMP-15 gene

in Chinese women suffering from PCOS. They suggested
a possible association between BMP-15 gene mutations
and PCOS patients [13]. Interestingly, Voorhuis et al.
reported a relationship between advanced menopause age
and BMP-15 gene single nucleotide polymorphism [14].
Wood et al. observed gene expression differences between
high-quality oocytes of normal and polycystic ovaries
where morphological discrepancy was not detected [15].
On the other hand, Wei et al. reported decreased BMP-15
expression in PCOS patients that have undergone COH
[16]. The contrariety between the study results may arise
from differences in PCR (nested vs. real-time) and RNA
extraction (Trizol vs. other kits) techniques.
Other researchers experimenting with animals
observed increased ovarian BMP-15 expression due to
gonadotropin stimulation in rat ovaries [17]. Pennetier
et al. researched the duration of bovine oocyte BMP15 expression from ovulation to the embryonic 8-cell
stage; they observed that BMP-15 transcription persisted
until embryonic genome activation [18]. Machado et al.
investigated the effect of BMP-15 on cattle oocyte during in
vitro maturation. They observed an enhancement in oocyte
maturation and embryo quality with BMP-15 support [19].
Inagaki and Shimasaki reported an increased ovulation
rate with decreased BMP-15 protein production in ewes.
Interestingly, they suggested that an increased ovulation
rate brings dizygotic twinning, but earlier consumption of
ovarian reserve may bring primary ovarian insufficiency
[20].
Gode et al. reported no relation between BMP-15
expression status and embryo quality on 81 infertile
patients undergoing COH+ICSI with GnRH agonist
suppression [21]. They included infertile couples suffering
from male factor, tubal factor, and unexplained infertility
in the study. The results of this study partially confirm the
results of Gode’s study. A negative impact of BMP-15 RNA
overexpression on the pregnancy rate was observed. The
mixed infertility etiology, pituitary downregulation with
GnRH agonist, and western blot analysis technique may
be the reasons for the differences between our study and
Gode’s study.
Researchers reported an increased FF BMP-15 level in
poor responder patients compared to normal responder
patients [22]. Wu et al. compared FF BMP-15 levels
with western blot analysis between 207 poor responder
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patients and 215 normal responder patients undergoing
COH+IVF+ET [8]. Interestingly, they did not report a
result for comparison of FF BMP-15 levels between poor
responders and normal responders. They divided their
poor responder population into two groups according to
the mean FF BMP-15 level having either a higher value
than the mean value or lower value than the mean value.
They had observed increased pregnancy and live birth rates
in higher FF BMP-15 level group compared to those in the
lower FF BMP-15 group. In a similar manner, in this study,
there was a difference in pregnancy rate between FF BMP15 overexpression and lower expression groups. However,
the significantly lower pregnancy rate was observed in the
overexpressed FF BMP-15 RNA group. This difference
may arise from population and RNA analysis differences
between this study and Wu’s study.
The limitations of this study are as follows: 1) the
comparison of FF BMP-15 RNA expression level for

embryo quality could not be done; 2) BMP-15 gene
mutation analysis could not be performed; 3) the study
population could be increased with the opportunity of
financial support.
In conclusion, significantly lower pregnancy rates were
observed on women with overexpression of FF BMP-15
RNA compared to women with lower expression of FF
BMP-15 RNA. However, there was no significant difference
for FF BMP-15 RNA expression levels among low, normal,
and high responder women.
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